BioNeutra International Stock (OTC: BIMO)

Latest news for BioNeutra International (OTC:BIMO) Stock

BioNeutra International Ltd currently has no business.

BIONEUTRA INTL LTD by BioNeutra International, Ltd.

BioNeutra International Ltd

<ul>
<li>3Q24 Contribution Profit1&nbsp;guidance&nbsp;of&nbsp;$35 million&nbsp;to&nbsp;$45 million</li>
<li>3Q24 Adjusted EBITDA1&nbsp;guidance&nbsp;of&nbsp;$(70)&nbsp;million to&nbsp;$(60)&nbsp;million</li>
</ul>

News

Guidance

OPEN

Opendoor Expects Q3 Revenue Of $1.2B - $1.3B, Est $1.59B

Merus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRUS#NASDAQ">MRUS</a>) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of $(0.76) by 6.58 percent. This is a 22.73 percent decrease over losses of $(0.66) per share from the same period last year. The company reported quarterly sales of $7.33 million which missed the analyst consensus estimate of $8.44 million by 13.13 percent. This is a 30.01 percent decrease over sales of $10.48 million the same period last year.

Earnings

Earnings Misses

MRUS

Merus Q2 EPS $(0.81) Misses $(0.76) Estimate, Sales $7.33M Miss $8.44M Estimate

WIIM

Bausch Health shares are trading lower. The company reported Q2 financial results.

LASR

nLIGHT Sees Q4 Revenues $53M-$58M vs $55.6M Est.

BFLY

Butterfly Network shares are trading higher after the company reported better-than-expected Q2 financial results.

Opendoor Technologies shares are trading lower. The company reported Q2 financial results.

Select Medical Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEM#NYSE">SEM</a>) reported quarterly earnings of $0.60 per share which missed the analyst consensus estimate of $0.61 by 1.64 percent. This is a 1.64 percent decrease over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $1.760 billion which beat the analyst consensus estimate of $1.745 billion by 0.88 percent. This is a 5.11 percent increase over sales of $1.675 billion the same period last year.

Earnings Beats

Select Medical Hldgs Q2 2024 Adj. EPS $0.60 Misses $0.61 Estimate, Sales $1.760B Beat $1.745B Estimate

Integral Ad Science shares are trading higher after the company reported better-than-expected Q2 financial results and issued FY24 revenue guidance above estimates.

Sprout Social shares are trading lower. The company reported Q2 financial results.

Transaction Represents Initial Residential Investment by RMR
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rmrgroup.com&amp;esheet=54103155&amp;newsitemid=20240801352089&amp;lan=en-US&amp;anchor=The+RMR+Group+%28Nasdaq%3A+RMR%29&amp;index=1&amp;md5=714b2221a7120d410fe1119f92191563">The RMR Group (NASDAQ:</a><a href="https://www.benzinga.com/stock/RMR#NASDAQ">RMR</a>) today announced that it has acquired The Ridge at Lowry, a 240-unit garden-style apartment community located at 10000 E. Alameda Avenue in Denver, Colorado, for a purchase price of $70.0 million. The property will be rebranded as ARIUM at Lowry under RMR's consumer-focused brand, ARIUM, and will undergo extensive interior and exterior renovations.

The RMR Group Announces Acquisition Of A Denver Multifamily Property For $70M

VREX

Varex Expects Q4 Revenues To Be $190M - $210M (Est $211.15M), Adj EPS To Be $0.00 - $0.15 (Est $0.22); Company Says Outlook Reflects Challenging Market Conditions

Microchip's financial performance in the June 2024 quarter met our expectations as customers continued to carefully manage their inventory levels in response to evolving demand dynamics," said Steve Sanghi, Executive Chair. "Today, our Board of Directors approved a year-over-year increase in our dividend of 10.7% to 45.4 cents per share, up from our August 2023 dividend of 41.0 cents per share.

Dividends

MCHP

Microchip Technology Increases Quarterly Cash Dividend YoY From $0.41 To $0.454 Per Share

XPOF

Xponential Fitness shares are trading lower after the company reported worse-than-expected Q2 revenue results. Also, the company reported a year-over-year decrease in Q2 adjusted EPS results.

OFS Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFS#NASDAQ">OFS</a>) reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.29 by 10.34 percent. This is a 31.58 percent decrease over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $11.165 million which missed the analyst consensus estimate of $11.740 million by 4.90 percent. This is a 23.14 percent decrease over sales of $14.526 million the same period last year.

OFS Capital Q2 2024 GAAP EPS $0.26 Misses $0.29 Estimate, Sales $11.165M Miss $11.740M Estimate

Dividends To Be Paid On September 16, 2024 To Stockholders Of Record On September 3, 2024

Boise Cascade Declares Quarterly Dividend Increase To $0.21 Per Share And Special Dividend Of $5.00 Per Share

Tanger Sees FY24 Core FFO $2.05-$2.12

SIGA

Siga Technologies shares are trading higher after the company reported a year-over-year increase in Q2 financial results.

The Company expects dry eye revenue for full year 2024 to be less than&nbsp;$3.0 million, including the&nbsp;$2.1 million&nbsp;of revenue achieved through the end of the&nbsp;second quarter.
The Company narrows&nbsp;guidance&nbsp;expectations for adjusted operating expenses1,3&nbsp;for full year 2024 to approximately&nbsp;$107.0 million&nbsp;to&nbsp;$109.0 million, representing a decrease of approximately&nbsp;1%&nbsp;to&nbsp;3%&nbsp;compared to 2023, versus its prior range of&nbsp;$107.0 million&nbsp;to&nbsp;$110.0 million.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

BioNeutra International

News

Latest news for BioNeutra International (OTC:BIMO) Stock